Leesha L Askew is a pharmacist who is specialized in Geriatric in Kawkawlin, Michigan. Patients can reach her at 1517 Chip Rd, Kawkawlin or contact her on 989-415-6771. Active license number of Leesha L Askew is 5302410751 for Geriatric in Michigan. Leesha L Askew is a pharmacist who is certified in geriatric pharmacy practice is designated as a “Certified Geriatric Pharmacist” (CGP). To become certified, candidates are expected to be knowledgeable about principles of geriatric pharmacotherapy and the provision of pharmaceutical care to the elderly.
Complete Profile:
Leesha L Askew speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Leesha L Askew
Specialization:
Geriatric
Gender:
Female
Location:
1517 Chip Rd, Kawkawlin, Michigan, 48631-9174
Phone:
989-415-6771
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Leesha L Askew are as mentioned below.
NPI Number:
1609198985
NPI Enumeration Date:
26 Feb, 2010
NPI Last Update On:
26 Feb, 2010
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Leesha L Askew are as mentioned below.
Specialization
License Number
State
Status
Geriatric
5302410751
Michigan
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1517 Chip Rd, Kawkawlin, Michigan
Zip:
48631-9174
Phone Number:
989-415-6771
Fax Number:
--
Patients can reach Leesha L Askew at 1517 Chip Rd, Kawkawlin, Michigan or can call on phone at 989-415-6771.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.